Literature DB >> 11238668

Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease.

R Marzari1, D Sblattero, F Florian, E Tongiorgi, T Not, A Tommasini, A Ventura, A Bradbury.   

Abstract

Celiac disease (CD) is an intestinal malabsorption characterized by intolerance to cereal proteins accompanied by immunological responses to dietary gliadins and tissue transglutaminase, an autoantigen located in the endomysium. Tissue transglutaminase belongs to the family of enzymes that catalyze protein cross-linking reactions and is constitutively expressed in many tissues as well as being activated during apoptosis. The role of gliadins in eliciting the immune response in CD and how transglutaminase is linked to the primary reaction are still unclear. In this work, we report the production and analysis of six phage Ab libraries from the peripheral and intestinal lymphocytes of three CD patients. We were able to isolate Abs to transglutaminase from all intestinal lymphocytes libraries but not from those obtained from peripheral lymphocytes. This is in contrast to Abs against gliadin, which could be obtained from all libraries, indicating that the humoral response against transglutaminase occurs at the local level, whereas that against gliadin occurs both peripherally and centrally. Abs from all three patients recognized the same transglutaminase epitopes with a bias toward the use of the V(H)5 Ab variable region family. The possible role of these anti-transglutaminase Abs in the onset of CD and associated autoimmune pathologies is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238668     DOI: 10.4049/jimmunol.166.6.4170

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

Review 1.  Ages of celiac disease: from changing environment to improved diagnostics.

Authors:  Alberto Tommasini; Tarcisio Not; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2011-08-28       Impact factor: 5.742

2.  Characterizing monoclonal antibody epitopes by filtered gene fragment phage display.

Authors:  Roberto Di Niro; Fortunato Ferrara; Tarcisio Not; Andrew R M Bradbury; Fernando Chirdo; Roberto Marzari; Daniele Sblattero
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

Review 3.  Celiac disease: is the atypical really typical? Summary of the recent National Institutes of Health Consensus Conference and latest advances.

Authors:  Swati Gadewar; Alessio Fasano
Journal:  Curr Gastroenterol Rep       Date:  2005-12

4.  Cryptic gluten intolerance in type 1 diabetes: identifying suitable candidates for a gluten free diet.

Authors:  D Sblattero; A Ventura; A Tommasini; L Cattin; S Martelossi; F Florian; R Marzari; A Bradbury; T Not
Journal:  Gut       Date:  2006-01       Impact factor: 23.059

5.  Latent coeliac disease or coeliac disease beyond villous atrophy?

Authors:  Katri Kaukinen; Pekka Collin; Markku Mäki
Journal:  Gut       Date:  2007-10       Impact factor: 23.059

Review 6.  Antibodies in celiac disease: implications beyond diagnostics.

Authors:  Sergio Caja; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

7.  Phage display of human antibodies from a patient suffering from coeliac disease and selection of isotype-specific scFv against gliadin.

Authors:  Claudio Rhyner; Michael Weichel; Philipp Hübner; Gernot Achatz; Kurt Blaser; Reto Crameri
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.

Authors:  I R Korponay-Szabó; T Halttunen; Z Szalai; K Laurila; R Király; J B Kovács; L Fésüs; M Mäki
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 9.  Coeliac disease and liver dysfunction.

Authors:  S Davison
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

Review 10.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.